TickerFactsScreenerDevelopers

Black Diamond Therapeutics, Inc. (BDTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $51.66M2019: $154.67M2020: $34.60M2021: $65.80M2022: $34.31M2023: $56.22M2024: $36.44M2025: $20.99M$20.99M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$20.99M-42.4%
2024$36.44M-35.2%
2023$56.22M+63.8%
2022$34.31M-47.8%
2021$65.80M+90.1%
2020$34.60M-77.6%
2019$154.67M+199.4%
2018$51.66M—